[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

N95 Masks: Market Segments: By Product Type (Mask with valve and Mask without valve); By Application (Respiratory infections, Pollution and Others); By Distribution Channel (Hospital pharmacies, Online stores and Retail Pharmacies); By Use (Disposable and Reusable); By End User (Hospital, Individuals and Industrial site) and Region – Global Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

May 2022 | 178 pages | ID: N9E958445CE4EN
Fatpos Global

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
N95 masks, also known as Filtering facepiece respirators are designed to filter airborne particles like dust, mists, and fumes and provide a close facial fit to the wearer. The term ‘N’ means the level of respirator that is non-oil and the number 95 refers to the efficiency of the mask i.e. it can remove 95% of 0.3 micron-particles. The edges of these masks are designed around the mouth and the nose to form a seal. The flirtation material on the mask is made up of electrostatic non-woven polypropylene fibre.Market Highlights
Global N95 Masks is expected to project a notable CAGR of 12.74 %in 2030.
Global N95 Masks to surpass USD 744.18 million by 2030 from USD 195.9 million in 2020 at a CAGR of 12.74 % in the coming years, i.e., 2020-30. Growing occurrences of respiratory disorders and increasing instances of infectious diseases are expected to have a positive impact on market growth.Global N95 Masks: Segments
Mask with valve segment to grow with the highest CAGR during 2020-30
Global N95 Masks is segmented by Product Type into Mask with a valve and Mask without a valve. Mask with a valve, the segment held the largest market share of XX.X% in the year 2019 due to the growing occurrence of respiratory infections across the globe. The mask with a valve encourages positive pressure and guarantees the user's unimpeded breathing. The use of a valve mask reduces the risk of re-breathing and allows for fresh air intake. The growing demand for these valve masks would further stimulate the growth of the market.Market Dynamics
Drivers
Rising prevalences of infectious diseases
Rising incidences of infectious diseases such as H1N1 influenza, SARS, MERS, and COVID19 are a threat to health which is expected to surge the demand for N95 masks. Various healthcare experts and scientists have recommended the use of N95 medical protective masks to prevent infection. N95 masks help prevent the droplets produced while coughing and sneezing from communicating with the surrounding environment. These droplets are enough for airborne illnesses and other pathogens to spread. Thus, these masks protect the wearer against airborne viruses by lowering the risk of viral infections and diseases which in turn boosting the N95 masks market.Restraint
Availability of substitutes
Factors such as the availability of substitutes and growing uses of homemade masks may hamper the growth of N95 masks in the future. Also, other factors including the limited supply and shortfall of these masks and the increasing number of competitive firms are anticipated to restrict the market growth.

Global N95 Masks:Key Players
3M.

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Teleflex Incorporated.
Honeywell International Inc.
Avon Protection.
MSA
ANSELL LTD
Gateway Safety, Inc.
Alpha Pro-Tec
Moldex-Metric
Cambridge Mask Co
Cardinal Health.
CERVA GROUP
DUKAL Corporation
FLOWTRONIX (FT)
GREENLINE.
Other Prominent Players
Global N95 Masks: Regions
Global N95 Masks is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. Global N95 Masks in North America held the largest market share of XX.X% in the year 2019. North America will continue to dominate the global N95 Masks. The growing prevalence of respiratory disorders, easy accessibility, and presence of major market players are likely to boost the market growth in this region. Besides, the rapid spread of the COVID-19 pandemic in the country is bolstering the demand for N95 masks.

1. EXECUTIVE SUMMARY

2. GLOBAL N95 MASKS MARKET

2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. RESEARCH METHODOLOGY

3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. AVERAGE PRICING ANALYSIS

5. MACRO-ECONOMIC INDICATORS

6. MARKET DYNAMICS

6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. CORRELATION & REGRESSION ANALYSIS

7.1. Correlation Matrix
7.2. Regression Matrix

8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE

9. RISK ANALYSIS

9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. GLOBAL N95 MASKS MARKET ANALYSIS

10.1. Porters Five Forces
  10.1.1. Threat of New Entrants
  10.1.2. Bargaining Power of Suppliers
  10.1.3. Threat of Substitutes
  10.1.4. Rivalry
10.2. PEST Analysis
  10.2.1. Political
  10.2.2. Economic
  10.2.3. Social
  10.2.4. Technological

11. GLOBAL N95 MASKS MARKET

11.1. Market Size & forecast, 2020A-2030F
  11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12. GLOBAL N95 MASKS MARKET: MARKET SEGMENTATION

12.1. By Regions
  12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product Type: Market Share (2020-2030F)
  12.2.1. Mask with valve, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.2. Mask without valve, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Application: Market Share (2020-2030F)
  12.3.1. Respiratory infections, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.2. Pollution, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Distribution Channel: Market Share (2020-2030F)
  12.4.1. Hospital Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.4.2. Online stores, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.4.3. Retail Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030
12.5. By Use: Market Share (2020-2030F)
  12.5.1. Disposable, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.5.2. Reusable, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.6. By End-Users: Market Share (2020-2030F)
  12.6.1. Hospital, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.6.2. Individuals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.6.3. Industrial sites, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

13. COMPANY PROFILE

13.1. 3M
  13.1.1. Company Overview
  13.1.2. Company Total Revenue (Financials)
  13.1.3. Market Potential
  13.1.4. Global Presence
  13.1.5. Key Performance Indicators
  13.1.6. SWOT Analysis
  13.1.7. Product Launch
13.2. Teleflex Incorporated.
13.3. Honeywell International Inc.
13.4. Avon Protection.
13.5. MSA
13.6. ANSELL LTD
13.7. Gateway Safety, Inc.
13.8. Alpha Pro-Tec
13.9. Moldex-Metric
13.10. Cambridge Mask Co
13.11. Cardinal Health.
13.12. CERVA GROUP
13.13. DUKAL Corporation
13.14. FLOWTRONIX (FT)
13.15. GREENLINE.
13.16. Other Prominent Players
Consultant Recommendation
*The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.


More Publications